Obesity drug rivals aim to unseat Zepbound, Ozempic – Indianapolis Business Journal
Eli Lilly and Novo are leading now, but there are multiple drug candidates waiting in the wings that could disrupt that duopoly in the future.
Stay updated with breaking news from Zeneca Plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly and Novo are leading now, but there are multiple drug candidates waiting in the wings that could disrupt that duopoly in the future.
/PRNewswire/ -- The global non-alcoholic steatohepatitis market size is estimated to grow by USD 11.21 billion from 2023-2027, according to Technavio. The...
(Bloomberg) — Technology stocks led declines in US equity futures Thursday after Meta Platforms Inc.’s disappointing outlook underscored the risk of volatility in a high-stakes earnings week. Nasdaq 100 contracts fell 0.9%, with Meta accounting for more than half of that decline. The Facebook parent tumbled as much as 15% in premarket trading after it…
Investors will also vote on executive pay packages, potentially turning LSEG CEO David Schwimmer into one of the highest-paid CEOs in the U.K., with $16.7 million in hand.
U.K. lenders are asking shareholders for permission to rewrite their bylaws to allow them to adjust how they structure pay for legions of their best investment bankers and traders.